| Followers | 79 |
| Posts | 3015 |
| Boards Moderated | 0 |
| Alias Born | 12/04/2020 |
Sunday, April 03, 2022 12:29:21 AM
It's being done the right way, but they have also been pathetic in patient enrollment. To only have enrolled approximately 750 patients in over a year, during a pandemic when billions of people had the virus being studied, is beyond unforgivable. And this is with more than 20 clinical sites. They should have been at 1000 like 8 months ago. And now they are ramping down the US trial and going to Turkey? For what reason? Just get it done already.
They need another 250 people roughly. Just offer $1,000 for participation and get this done.
They need another 250 people roughly. Just offer $1,000 for participation and get this done.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
